ArticleJCO oncology advances2026

Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Ellen M Lavoie Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.